Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner

J Biol Chem. 2021 Jul;297(1):100775. doi: 10.1016/j.jbc.2021.100775. Epub 2021 May 20.

Abstract

Cellular pyruvate is an essential metabolite at the crossroads of glycolysis and oxidative phosphorylation, capable of supporting fermentative glycolysis by reduction to lactate mediated by lactate dehydrogenase (LDH) among other functions. Several inherited diseases of mitochondrial metabolism impact extracellular (plasma) pyruvate concentrations, and [1-13C]pyruvate infusion is used in isotope-labeled metabolic tracing studies, including hyperpolarized magnetic resonance spectroscopic imaging. However, how these extracellular pyruvate sources impact intracellular metabolism is not clear. Herein, we examined the effects of excess exogenous pyruvate on intracellular LDH activity, extracellular acidification rates (ECARs) as a measure of lactate production, and hyperpolarized [1-13C]pyruvate-to-[1-13C]lactate conversion rates across a panel of tumor and normal cells. Combined LDH activity and LDHB/LDHA expression analysis intimated various heterotetrameric isoforms comprising LDHA and LDHB in tumor cells, not only canonical LDHA. Millimolar concentrations of exogenous pyruvate induced substrate inhibition of LDH activity in both enzymatic assays ex vivo and in live cells, abrogated glycolytic ECAR, and inhibited hyperpolarized [1-13C]pyruvate-to-[1-13C]lactate conversion rates in cellulo. Of importance, the extent of exogenous pyruvate-induced inhibition of LDH and glycolytic ECAR in live cells was highly dependent on pyruvate influx, functionally mediated by monocarboxylate transporter-1 localized to the plasma membrane. These data provided evidence that highly concentrated bolus injections of pyruvate in vivo may transiently inhibit LDH activity in a tissue type- and monocarboxylate transporter-1-dependent manner. Maintaining plasma pyruvate at submillimolar concentrations could potentially minimize transient metabolic perturbations, improve pyruvate therapy, and enhance quantification of metabolic studies, including hyperpolarized [1-13C]pyruvate magnetic resonance spectroscopic imaging and stable isotope tracer experiments.

Keywords: (13)C magnetic resonance spectroscopy; LDH; MRSI; [1-(13)C]pyruvate; cancer metabolism; hyperpolarized (13)C; lactate dehydrogenase; stable isotope.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acids / metabolism
  • Buffers
  • Carbon Isotopes
  • Cell Extracts
  • Cell Line, Tumor
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Extracellular Space / chemistry
  • Glycolysis / drug effects
  • Humans
  • Inhibitory Concentration 50
  • Kinetics
  • L-Lactate Dehydrogenase / antagonists & inhibitors*
  • L-Lactate Dehydrogenase / metabolism
  • Lactic Acid / biosynthesis
  • Monocarboxylic Acid Transporters / metabolism*
  • Pyruvic Acid / pharmacology*
  • Substrate Specificity / drug effects
  • Symporters / metabolism*

Substances

  • Acids
  • Buffers
  • Carbon Isotopes
  • Cell Extracts
  • Monocarboxylic Acid Transporters
  • Symporters
  • monocarboxylate transport protein 1
  • Lactic Acid
  • Pyruvic Acid
  • L-Lactate Dehydrogenase
  • Carbon-13